Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05003362 · ClinicalTrials.gov registry record · NA

ACT for High Frequency Migraine; A Virtual Mindfulness Intervention

A NA study of Migraine, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05003362: Completed NA study of Migraine, sponsored by Brigham and Women's Hospital.

NCT05003362 is a NA study of Migraine that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 75 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05003362, a NA study of Migraine, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Mindfulness Training specifically for pain to be offered to migraine patients

Primary Outcome

Demonstrate that 48 patients can be successfully enrolled and randomized

Conditions Studied

Interventions

  • BEHAVIORAL ACT

Study Locations (1)

Massachusetts

  • Brigham and Womens Hospital - Boston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2020-10-25
Est. Completion 2021-11-23
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT05003362 record still lists

NCT05003362 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which ACT is the first listed.

NCT05003362 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05003362 about?

NCT05003362 is a clinical study titled "ACT for High Frequency Migraine; A Virtual Mindfulness Intervention". Mindfulness Training specifically for pain to be offered to migraine patients

What is the current status of trial NCT05003362?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-10-25. Estimated completion is 2021-11-23.

What conditions does trial NCT05003362 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT05003362?

The interventions under investigation include: ACT (BEHAVIORAL).

Who is sponsoring clinical trial NCT05003362?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05003362 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05003362's enrollment target sits among peer trials

75 68th of 102 higher than 35 of 102 other Migraine trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05003362, the US trial registry maintained by the National Library of Medicine. NCT05003362 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.